Dmitry Balyasny’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Buy
+18,871
New +$525K ﹤0.01% 2485
2026
Q1
Sell
-1,541,160
Closed -$35.6M 3492
2025
Q4
$35.6M Sell
1,541,160
-272,348
-15% -$7.02M 0.05% 467
2025
Q3
$48.7M Buy
+1,813,508
New +$43.2M 0.06% 371
2024
Q4
Sell
-12,847
Closed -$477K 3243
2024
Q3
$477K Buy
+12,847
New +$479K ﹤0.01% 2277
2024
Q2
Sell
-24,311
Closed -$931K 3085
2024
Q1
$931K Buy
+24,311
New +$790K ﹤0.01% 1821
2023
Q1
Sell
-181
Closed -$8.79K 3122
2022
Q4
$8.79K Buy
+181
New +$11.4K ﹤0.01% 2574
2022
Q2
Sell
-14,737
Closed -$1.18M 3154
2022
Q1
$1.18M Buy
+14,737
New +$1.1M ﹤0.01% 1580
2018
Q4
Sell
-5,040
Closed -$242K 1742
2018
Q3
$242K Buy
+5,040
New +$206K ﹤0.01% 1552
2018
Q2
Sell
-12,034
Closed -$178K 2128
2018
Q1
$178K Buy
+12,034
New +$188K ﹤0.01% 1775

Other funds holding STAA

Dmitry Balyasny's STAA Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in STAAR Surgical (STAA) in Q2 2026: 18,871 shares worth $541K. The stake represents ﹤0.01% of the portfolio and ranks #2485 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in STAA as recently as Q4 2025.

Dmitry Balyasny first reported a position in STAA in Q1 2018 and has held it in 9 quarters since. The position peaked at $48.7M in Q3 2025. 199 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Dmitry Balyasny held 18,871 shares of STAAR Surgical worth $541K as of Q2 2026.
  • STAAR Surgical was a new Dmitry Balyasny position in Q2 2026.
  • STAAR Surgical made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2485 holding.
  • Dmitry Balyasny first reported a position in STAAR Surgical in Q1 2018 and has held it in 9 quarters since.
  • Dmitry Balyasny's STAAR Surgical position peaked at $48.7M in Q3 2025.
  • 199 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.